Hatemi, G. Et Al. 2015. Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study. NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.16 , 1510-1518.

Hatemi, G., Melikoglu, M., Tunc, R., KORKMAZ, C., ÖZTÜRK, B. T., Mat, C., ... Merkel, P. A.(2015). Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study. NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.16, 1510-1518.

Hatemi, Gulen Et Al. "Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study," NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.16, 1510-1518, 2015

Hatemi, Gulen Et Al. "Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study." NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.16, pp.1510-1518, 2015

Hatemi, G. Et Al. (2015) . "Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study." NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.16, pp.1510-1518.

@article{article, author={Gulen Hatemi Et Al. }, title={Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2015, pages={1510-1518} }